Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2024 Earnings Call Transcript
Aurinia Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.07464, expectations were $-0.17.
Source: insidermonkey.com
📰 Farzin Haque News
Farzin Haque News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Farzin Haque. Real-time updates on events, politics, business and more.
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Illumina (NASDAQ:ILMN), Hawaiian Electric Indus (NYSE:HE)
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Source: benzinga.com
Jefferies upgrades this little-known biotech stock, with more than 100% upside
This biotech company could rally if its drug successfully treats autoimmune diseases affecting the kidneys.
Source: cnbc.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q3 2023 Earnings Call Transcript
Operator: Greetings. Welcome to Aurinia Pharmaceuticals Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2023 Earnings Call Transcript
Operator: Greetings. And welcome to Aurinia Pharmaceuticals Incorporated Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Source: insidermonkey.com